Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Dyslipidemia

Free Subscription Articles published in Am J Cardiol Retrieve available abstracts of 100 articles: HTML format

Single Articles

May 2008
1. BRASS EP , Vassil T, Replogle A, Hwang P, et al
   Can consumers self-select for appropriate use of an over-the-counter statin? The Self Evaluation of Lovastatin to Enhance Cholesterol Treatment Study.
   Am J Cardiol. 2008;101:1448-55.
   PubMed     Related articles    Abstract available
   
   
   
2. BALLANTYNE CM , Davidson MH, McKenney J, Keller LH, et al
   Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
   Am J Cardiol. 2008;101:1428-36.
   PubMed     Related articles    Abstract available
   
   
   
3. HOVANESYAN A , Rich MW
   Outcomes of acute myocardial infarction in nonagenarians.
   Am J Cardiol. 2008;101:1379-83.
   PubMed     Related articles    Abstract available
   
   
   
4. ALBERT NM , Birtcher KK, Cannon CP, Goff DC Jr, et al
   Factors Associated With Discharge Lipid-Lowering Drug Prescription in Patients Hospitalized for Coronary Artery Disease (from the Get With the Guidelines Database).
   Am J Cardiol. 2008;101:1242-6.
   PubMed     Related articles    Abstract available
   
   
   April 2008
5. BROWN BG , Zhao XQ
   Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk.
   Am J Cardiol. 2008;101.
   PubMed     Related articles    Abstract available
   
   
   
6. KNOPP RH , Paramsothy P, Atkinson B, Dowdy A, et al
   Comprehensive lipid management versus aggressive low-density lipoprotein lowering to reduce cardiovascular risk.
   Am J Cardiol. 2008;101.
   PubMed     Related articles    Abstract available
   
   
   
7. SCANU AM , Bamba R
   Niacin and lipoprotein(a): facts, uncertainties, and clinical considerations.
   Am J Cardiol. 2008;101.
   PubMed     Related articles    Abstract available
   
   
   
8. POLONSKY TS , Davidson MH
   Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy.
   Am J Cardiol. 2008;101.
   PubMed     Related articles    Abstract available
   
   
   
9. DAVIDSON MH
   Niacin use and cutaneous flushing: mechanisms and strategies for prevention.
   Am J Cardiol. 2008;101.
   PubMed     Related articles    Abstract available
   
   
   
10. DAVIDSON MH , Ballantyne CM
    Niacin therapy: an evolving paradigm for the management of mixed dyslipidemia and low high-density lipoprotein cholesterol. Introduction.
    Am J Cardiol. 2008;101.
    PubMed     Related articles   
    
    
    
11. MILLER M , Ginsberg HN, Schaefer EJ
    Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.
    Am J Cardiol. 2008;101:1003-8.
    PubMed     Related articles    Abstract available
    
    
    
12. BARAC A , Campia U, Matuskey LA, Lu L, et al
    Effects of peroxisome proliferator-activated receptor-gamma activation with pioglitazone on plasma adipokines in nondiabetic patients with either hypercholesterolemia or hypertension.
    Am J Cardiol. 2008;101:980-5.
    PubMed     Related articles    Abstract available
    
    
    
13. SUKHIJA R , Bursac Z, Kakar P, Fink L, et al
    Effect of statins on the development of renal dysfunction.
    Am J Cardiol. 2008;101:975-9.
    PubMed     Related articles    Abstract available
    
    
    March 2008
14. PAOLINI JF , Mitchel YB, Reyes R, Kher U, et al
    Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia.
    Am J Cardiol. 2008;101:625-30.
    PubMed     Related articles    Abstract available
    
    
    February 2008
15. KAPOOR JR
    Postprandial hyperglycemia: are all sulfonylureas created equal?
    Am J Cardiol. 2008;101:554-5.
    PubMed     Related articles   
    
    
    
16. MAY HT , Anderson JL, Pearson RR, Jensen JR, et al
    Comparison of Effects of Simvastatin Alone Versus Fenofibrate Alone Versus Simvastatin Plus Fenofibrate on Lipoprotein Subparticle Profiles in Diabetic Patients With Mixed Dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen Study).
    Am J Cardiol. 2008;101:486-9.
    PubMed     Related articles    Abstract available
    
    
    
17. ATHYROS VG , Tziomalos K, Kakafika AI, Koumaras H, et al
    Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.
    Am J Cardiol. 2008;101:483-5.
    PubMed     Related articles    Abstract available
    
    
    
18. AI M , Otokozawa S, Asztalos BF, Nakajima K, et al
    Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels.
    Am J Cardiol. 2008;101:315-8.
    PubMed     Related articles    Abstract available
    
    
    December 2007
19. BELLOCCHIO L , Vicennati V, Cervino C, Pasquali R, et al
    The endocannabinoid system in the regulation of cardiometabolic risk factors.
    Am J Cardiol. 2007;100.
    PubMed     Related articles    Abstract available
    
    
    
20. EHARA S , Naruko T, Kobayashi Y, Kataoka T, et al
    Comparison of clinical characteristics and arterial remodeling by intravascular ultrasonic imaging in three age groups (</=55, 56 to 69 and >/=70 years) of Japanese patients with acute myocardial infarction.
    Am J Cardiol. 2007;100:1713-7.
    PubMed     Related articles    Abstract available
    
    
    
21. RADER DJ
    Liver X receptor and farnesoid X receptor as therapeutic targets.
    Am J Cardiol. 2007;100.
    PubMed     Related articles    Abstract available
    
    
    November 2007
22. ARCA M , Montali A, Valiante S, Campagna F, et al
    Usefulness of Atherogenic Dyslipidemia for Predicting Cardiovascular Risk in Patients With Angiographically Defined Coronary Artery Disease.
    Am J Cardiol. 2007;100:1511-1516.
    PubMed     Related articles    Abstract available
    
    
    
23. ALSHEIKH-ALI AA , Lin JL, Abourjaily P, Ahearn D, et al
    Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Am J Cardiol. 2007;100:1499-501.
    PubMed     Related articles    Abstract available
    
    
    
24. OPOLE IO , Belmont JM, Kumar A, Moriarty PM, et al
    Effect of low-density lipoprotein apheresis on inflammatory and noninflammatory high-density lipoprotein cholesterol.
    Am J Cardiol. 2007;100:1416-8.
    PubMed     Related articles    Abstract available
    
    
    
25. STEIN EA , Amerena J, Ballantyne CM, Brice E, et al
    Long-Term Efficacy and Safety of Rosuvastatin 40 mg in Patients With Severe Hypercholesterolemia.
    Am J Cardiol. 2007;100:1387-96.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    October 2007
26. BETTERIDGE DJ , Gibson JM, Sager PT
    Comparison of Effectiveness of Rosuvastatin Versus Atorvastatin on the Achievement of Combined C-Reactive Protein (<2 mg/L) and Low-Density Lipoprotein Cholesterol (<70 mg/dl) Targets in Patients With Type 2 Diabetes Mellitus (from the ANDROMEDA St
    Am J Cardiol. 2007;100:1245-8.
    PubMed     Related articles    Abstract available
    
    
    
27. YE ZX , Cheng HM, Chiou KR, Huang PH, et al
    Relation of Coronary Artery Calcium to Flow-Mediated Dilation and C-Reactive Protein Levels in Asymptomatic Patients With Heterozygous Familial Hypercholesterolemia.
    Am J Cardiol. 2007;100:1119-1123.
    PubMed     Related articles    Abstract available
    
    
    September 2007
28. O'KEEFE JH , Bell DS
    Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor.
    Am J Cardiol. 2007;100:899-904.
    PubMed     Related articles    Abstract available
    
    
    
29. CAMPBELL CY , Nasir K, Sarwar A, Meneghelo RS, et al
    Combined effect of high low-density lipoprotein cholesterol and metabolic syndrome on subclinical coronary atherosclerosis in white men without clinical evidence of myocardial ischemia.
    Am J Cardiol. 2007;100:840-3.
    PubMed     Related articles    Abstract available
    
    
    
30. ZHAO D , Grundy SM, Wang W, Liu J, et al
    Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged chinese.
    Am J Cardiol. 2007;100:835-9.
    PubMed     Related articles    Abstract available
    
    
    August 2007
31. RITZ E
    Total cardiovascular risk management.
    Am J Cardiol. 2007;100.
    PubMed     Related articles    Abstract available
    
    
    
32. BACKES JM , Moriarty PM, Ruisinger JF, Gibson CA, et al
    Effects of once weekly rosuvastatin among patients with a prior statin intolerance.
    Am J Cardiol. 2007;100:554-5.
    PubMed     Related articles    Abstract available
    
    
    
33. NI M , Zhang XH, Jiang SL, Zhang Y, et al
    Homocystinemia as an independent risk factor in the chinese population at a high risk of coronary artery disease.
    Am J Cardiol. 2007;100:455-8.
    PubMed     Related articles    Abstract available
    
    
    
34. KARALIS DG , Ishisaka DY, Luo D, Ntanios F, et al
    Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
    Am J Cardiol. 2007;100:445-9.
    PubMed     Related articles    Abstract available
    
    
    July 2007
35. SIERRA-JOHNSON J , Romero-Corral A, Lopez-Jimenez F, Gami AS, et al
    Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population.
    Am J Cardiol. 2007;100:234-9.
    PubMed     Related articles    Abstract available
    
    
    
36. RAJAGOPALAN S , Zannad F, Radauceanu A, Glazer R, et al
    Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension.
    Am J Cardiol. 2007;100:222-6.
    PubMed     Related articles    Abstract available
    
    
    
37. KOSTIS JB
    Treating hypercholesterolemia and hypertension based on lifetime global risk.
    Am J Cardiol. 2007;100:138-42.
    PubMed     Related articles   
    
    
    June 2007
38. GINSBERG HN , Bonds DE, Lovato LC, Crouse JR, et al
    Evolution of the Lipid Trial Protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.
    Am J Cardiol. 2007;99.
    PubMed     Related articles    Abstract available
    
    
    
39. GOFF DC JR , Gerstein HC, Ginsberg HN, Cushman WC, et al
    Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.
    Am J Cardiol. 2007;99.
    PubMed     Related articles    Abstract available
    
    
    
40. CHEW EY , Ambrosius WT, Howard LT, Greven CM, et al
    Rationale, Design, and Methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE).
    Am J Cardiol. 2007;99.
    PubMed     Related articles    Abstract available
    
    
    
41. GILLESPIE MJ , Davis CJ, Lambert ND, Costello FM, et al
    Measuring and treating serum lipids in patients in a chest pain observation unit.
    Am J Cardiol. 2007;99:1718-20.
    PubMed     Related articles    Abstract available
    
    
    
42. PEARSON T , Ballantyne C, Sisk C, Shah A, et al
    Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Am J Cardiol. 2007;99:1706-1713.
    PubMed     Related articles    Abstract available
    
    
    
43. FRIEDEWALD VE , Gheorghiade M, Yancy CW, Young JB, et al
    The Editor's Roundtable: Acute Decompensated Heart Failure.
    Am J Cardiol. 2007;99:1560-7.
    PubMed     Related articles   
    
    
    
44. DEEDWANIA PC , Gupta M, Stein M, Ycas J, et al
    Comparison of Rosuvastatin Versus Atorvastatin in South-Asian Patients at Risk of Coronary Heart Disease (from the IRIS Trial).
    Am J Cardiol. 2007;99:1538-43.
    PubMed     Related articles    Abstract available
    
    
    May 2007
45. CASO G , Kelly P, McNurlan MA, Lawson WE, et al
    Effect of coenzyme q10 on myopathic symptoms in patients treated with statins.
    Am J Cardiol. 2007;99:1409-12.
    PubMed     Related articles    Abstract available
    
    
    
46. MAINOUS AG 3RD , Koopman RJ, Diaz VA, Everett CJ, et al
    A coronary heart disease risk score based on patient-reported information.
    Am J Cardiol. 2007;99:1236-41.
    PubMed     Related articles    Abstract available
    
    
    
47. KANWAR M , Rosman HS, Fozo PK, Fahmy S, et al
    Usefulness of carotid ultrasound to improve the ability of stress testing to predict coronary artery disease.
    Am J Cardiol. 2007;99:1196-200.
    PubMed     Related articles    Abstract available
    
    
    March 2007
48. DAVIDSON MH , Armani A, McKenney JM, Jacobson TA, et al
    Safety considerations with fibrate therapy.
    Am J Cardiol. 2007;99.
    PubMed     Related articles    Abstract available
    
    
    
49. ASZTALOS BF , Le Maulf F, Dallal GE, Stein E, et al
    Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.
    Am J Cardiol. 2007;99:681-5.
    PubMed     Related articles    Abstract available
    
    
    
50. BALLANTYNE CM , Weiss R, Moccetti T, Vogt A, et al
    Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER Study).
    Am J Cardiol. 2007;99:673-80.
    PubMed     Related articles    Abstract available
    
    
    February 2007
51. GOTTO AM JR
    Cardiologist's Role in Improving Glucose Control and Global Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus.
    Am J Cardiol. 2007;99.
    PubMed     Related articles    Abstract available
    
    
    
52. LLOYD-JONES DM , Dyer AR, Wang R, Daviglus ML, et al
    Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (chicago heart association detection project in industry).
    Am J Cardiol. 2007;99:535-40.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
53. LIAO JK
    Safety and efficacy of statins in Asians.
    Am J Cardiol. 2007;99:410-4.
    PubMed     Related articles    Abstract available
    
    
    
54. ST-PIERRE J , Lemieux I, Perron P, Brisson D, et al
    Relation of the "hypertriglyceridemic waist" phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus.
    Am J Cardiol. 2007;99:369-73.
    PubMed     Related articles    Abstract available
    
    
    January 2007
55. MACKIE BD , Satija S, Nell C, Miller J 3rd, et al
    Monday, Wednesday, and Friday dosing of rosuvastatin in patients previously intolerant to statin therapy.
    Am J Cardiol. 2007;99:291.
    PubMed     Related articles    Abstract available
    
    
    
56. VOGEL JA , Franklin BA, Zalesin KC, Trivax JE, et al
    Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery.
    Am J Cardiol. 2007;99:222-6.
    PubMed     Related articles    Abstract available
    
    
    
57. BODEN WE , O'rourke RA, Teo KK, Hartigan PM, et al
    The Evolving Pattern of Symptomatic Coronary Artery Disease in the United States and Canada: Baseline Characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial.
    Am J Cardiol. 2007;99:208-12.
    PubMed     Related articles    Abstract available
    
    
    
58. SHAPIRO H , Bruck R
    Omega-3 may indirectly reduce hepatocyte triglycerides through modulation of hyperinsulinemia, cytokines and adipocytokines.
    Am J Cardiol. 2007;99:146.
    PubMed     Related articles   
    
    
    
59. ITO MK , Marrs J, Williams C
    Omacor effects on serum lipids and clinical outcome.
    Am J Cardiol. 2007;99:145.
    PubMed     Related articles   
    
    
    
60. FRIEDEWALD VE , Jones PH, Kaplan NM, Pool JL, et al
    The Editor's Roundtable: Concurrent Hypertension and Dyslipidemia.
    Am J Cardiol. 2007;99:134-44.
    PubMed     Related articles   
    
    
    
61. DEFARIA YEH D , Freeman MW, Meigs JB, Grant RW, et al
    Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    Am J Cardiol. 2007;99:1-4.
    PubMed     Related articles    Abstract available
    
    
    December 2006
62. LIANG HY , Cauduro S, Pellikka P, Wang J, et al
    Usefulness of two-dimensional speckle strain for evaluation of left ventricular diastolic deformation in patients with coronary artery disease.
    Am J Cardiol. 2006;98:1581-6.
    PubMed     Related articles    Abstract available
    
    
    November 2006
63. ROBINSON JG , Stone NJ
    Identifying patients for aggressive cholesterol lowering: the risk curve concept.
    Am J Cardiol. 2006;98:1405-8.
    PubMed     Related articles    Abstract available
    
    
    
64. NAWAZ H , Comerford BP, Njike VY, Dhond AJ, et al
    Repeated serum lipid measurements during the peri-hospitalization period.
    Am J Cardiol. 2006;98:1379-82.
    PubMed     Related articles    Abstract available
    
    
    
65. RAVIPATI G , Aronow WS, Ahn C, Channamsetty V, et al
    Incidence of new stroke or new myocardial infarction or death in patients with severe carotid arterial disease treated with and without statins.
    Am J Cardiol. 2006;98:1170-1.
    PubMed     Related articles    Abstract available
    
    
    October 2006
66. MESSERLI FH , Bangalore S, Egan BM, Julius S, et al
    Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension?
    Am J Cardiol. 2006;98:1122.
    PubMed     Related articles   
    
    
    
67. PANZA F , Capurso C, Solfrizzi V
    Cardiovascular factors and cognitive impairment: a role for unsaturated Fatty acids and mediterranean diet?
    Am J Cardiol. 2006;98:1120-1.
    PubMed     Related articles   
    
    
    
68. ALLISON MA , Laughlin GA, Barrett-Connor E
    Association between the ankle-brachial index and carotid intimal medial thickness in the Rancho Bernardo Study.
    Am J Cardiol. 2006;98:1105-9.
    PubMed     Related articles    Abstract available
    
    
    
69. SAKAI K , Nakagawa Y, Soga Y, Ando K, et al
    Comparison of 30-day outcomes in patients <75 years of age versus >/=75 years of age with acute myocardial infarction treated by primary coronary angioplasty.
    Am J Cardiol. 2006;98:1018-21.
    PubMed     Related articles    Abstract available
    
    
    
70. COOPER-DEHOFF R , Cohen JD, Bakris GL, Messerli FH, et al
    Predictors of Development of Diabetes Mellitus in Patients With Coronary Artery Disease Taking Antihypertensive Medications (Findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
    Am J Cardiol. 2006;98:890-4.
    PubMed     Related articles    Abstract available
    
    
    September 2006
71. LLORET R , Ycas J, Stein M, Haffner S, et al
    Comparison of Rosuvastatin Versus Atorvastatin in Hispanic-Americans With Hypercholesterolemia (from the STARSHIP Trial).
    Am J Cardiol. 2006;98:768-73.
    PubMed     Related articles    Abstract available
    
    
    
72. SOROKIN AV , Duncan B, Panetta R, Thompson PD, et al
    Rhabdomyolysis associated with pomegranate juice consumption.
    Am J Cardiol. 2006;98:705-6.
    PubMed     Related articles    Abstract available
    
    
    
73. DEVARAJ S , Autret B, Jialal I
    Effects of Colesevelam Hydrochloride (WelChol) on Biomarkers of Inflammation in Patients With Mild Hypercholesterolemia.
    Am J Cardiol. 2006;98:641-3.
    PubMed     Related articles    Abstract available
    
    
    August 2006
74. BAYS H
    Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids.
    Am J Cardiol. 2006;98.
    PubMed     Related articles    Abstract available
    
    
    
75. REIFFEL JA , McDonald A
    Antiarrhythmic effects of omega-3 fatty acids.
    Am J Cardiol. 2006;98.
    PubMed     Related articles    Abstract available
    
    
    
76. NAMBI V , Ballantyne CM
    Combination therapy with statins and omega-3 fatty acids.
    Am J Cardiol. 2006;98.
    PubMed     Related articles    Abstract available
    
    
    
77. CHENG TO
    Prevalence of metabolic syndrome in Chinese adults has been underestimated by using US-Based National Cholesterol Education Programs Adult Treatment Panel III and World Health Organization criteria.
    Am J Cardiol. 2006;98:422-3.
    PubMed     Related articles   
    
    
    
78. SINGH M , Lennon RJ, Roger VL, Rihal CS, et al
    Relation of preprocedural statin therapy to in-hospital procedural complications following percutaneous coronary interventions in patients with hyperlipidemia.
    Am J Cardiol. 2006;98:325-30.
    PubMed     Related articles    Abstract available
    
    
    July 2006
79. WONG ND , Lopez V, Tang S, Williams GR, et al
    Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States.
    Am J Cardiol. 2006;98:204-8.
    PubMed     Related articles    Abstract available
    
    
    
80. ELKOUSTAF RA , Mamkin I, Mather JF, Murphy D, et al
    Comparison of Results of Percutaneous Coronary Intervention for Non-ST-Elevation Acute Myocardial Infarction or Unstable Angina Pectoris in Men Versus Women.
    Am J Cardiol. 2006;98:182-6.
    PubMed     Related articles    Abstract available
    
    
    
81. MEYERS CD , McCarren M, Wong ND, Abraira C, et al
    Baseline Achievement of Lipid Goals and Usage of Lipid Medications in Patients With Diabetes Mellitus (from the Veterans Affairs Diabetes Trial).
    Am J Cardiol. 2006;98:63-5.
    PubMed     Related articles    Abstract available
    
    
    June 2006
82. ALBU J , Gottlieb SH, August P, Nesto RW, et al
    Modifications of coronary risk factors.
    Am J Cardiol. 2006;97.
    PubMed     Related articles    Abstract available
    
    
    
83. BROOKS MM , Frye RL, Genuth S, Detre KM, et al
    Hypotheses, Design, and Methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
    Am J Cardiol. 2006;97.
    PubMed     Related articles    Abstract available
    
    
    
84. KLONER RA , Jackson G, Hutter AM, Mittleman MA, et al
    Cardiovascular Safety Update of Tadalafil: Retrospective Analysis of Data from Placebo-Controlled and Open-Label Clinical Trials of Tadalafil With As Needed, Three Times-per-Week or Once-a-Day Dosing.
    Am J Cardiol. 2006;97:1778-84.
    PubMed     Related articles    Abstract available
    
    
    
85. CECCHI E , Marcucci R, Poli D, Antonucci E, et al
    Hyperviscosity as a possible risk factor for cerebral ischemic complications in atrial fibrillation patients.
    Am J Cardiol. 2006;97:1745-8.
    PubMed     Related articles    Abstract available
    
    
    
86. CROUSE JR 3RD , Elam MB, Robinson JG, Ambrosius WT, et al
    Cholesterol management: targeting a lower low-density lipoprotein cholesterol concentration increases adult treatment panel-III goal attainment.
    Am J Cardiol. 2006;97:1667-9.
    PubMed     Related articles   
    
    
    
87. VIDT DG , Harris S, McTaggart F, Ditmarsch M, et al
    Effect of short-term rosuvastatin treatment on estimated glomerular filtration rate.
    Am J Cardiol. 2006;97:1602-6.
    PubMed     Related articles    Abstract available
    
    
    May 2006
88. SHAW LJ , Berman DS, Hendel RC, Alazraki N, et al
    Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium-99m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus.
    Am J Cardiol. 2006;97:1538-44.
    PubMed     Related articles    Abstract available
    
    
    
89. RADHA V , Mohan V, Vidya R, Ashok AK, et al
    Association of lipoprotein lipase Hind III and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians.
    Am J Cardiol. 2006;97:1337-42.
    PubMed     Related articles    Abstract available
    
    
    
90. RUBINSHTEIN R , Halon DA, Jaffe R, Shahla J, et al
    Relation between obesity and severity of coronary artery disease in patients undergoing coronary angiography.
    Am J Cardiol. 2006;97:1277-80.
    PubMed     Related articles    Abstract available
    
    
    April 2006
91. CZIRAKY MJ , Willey VJ, McKenney JM, Kamat SA, et al
    Statin safety: an assessment using an administrative claims database.
    Am J Cardiol. 2006;97.
    PubMed     Related articles    Abstract available
    
    
    
92. JACOBSON TA
    Statin safety: lessons from new drug applications for marketed statins.
    Am J Cardiol. 2006;97.
    PubMed     Related articles    Abstract available
    
    
    
93. NASH DT , Fillit H
    Cardiovascular disease risk factors and cognitive impairment.
    Am J Cardiol. 2006;97:1262-5.
    PubMed     Related articles    Abstract available
    
    
    
94. BAYS HE , Davidson M, Jones MR, Abby SL, et al
    Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Am J Cardiol. 2006;97:1198-205.
    PubMed     Related articles    Abstract available
    
    
    
95. ABUISSA H , Lavie C, Spertus J, O'Keefe J Jr, et al
    Personal health habits of American cardiologists.
    Am J Cardiol. 2006;97:1093-6.
    PubMed     Related articles    Abstract available
    
    
    
96. TANEVA E , Borucki K, Wiens L, Makarova R, et al
    Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
    Am J Cardiol. 2006;97:1002-6.
    PubMed     Related articles    Abstract available
    
    
    March 2006
97. WOJNICZ R , Wilczek K, Nowalany-Kozielska E, Szygula-Jurkiewicz B, et al
    Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels.
    Am J Cardiol. 2006;97:899-904.
    PubMed     Related articles    Abstract available
    
    
    
98. SIMON JA , Lin F, Hulley SB, Blanche PJ, et al
    Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study.
    Am J Cardiol. 2006;97:843-50.
    PubMed     Related articles    Abstract available
    
    
    
99. AGARWAL R
    Effects of statins on renal function.
    Am J Cardiol. 2006;97:748-55.
    PubMed     Related articles    Abstract available
    
    
    February 2006
100. NAM BH , Kannel WB, D'Agostino RB
     Search for an optimal atherogenic lipid risk profile: from the Framingham Study.
     Am J Cardiol. 2006;97:372-5.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: